97095 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof Translation products from oncogenes
Modulators of MYC and methods of using the same
#302Compositions and methods for the treatment of prostate carcinoma
#303ANTI-5T4 ANTIBODIES AND USES THEREOF
#304Expansion of adult stem cells in vitro
#305Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
#306Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
#307KIF5B-RET fusion molecules and uses thereof
#308Method for measuring anti-WT1 antibody
#309RNA engineered T cells for the treatment of cancer
#310Method for determining effectiveness of cancer treatment by assessing the presence of a KIF5B-RET chimeric gene
#311Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
#312Suppression of prostate cancer using a targeted clostridial neurotoxin
#313Method for preparing human neoplastically transformed cells
#314Cell for use in immunotherapy which contains modified nucleic acid construct encoding wilms tumor gene product or fragment thereof, method for producing said cell, and said nucleic acid construct
#315Lipopeptide inhibitors of RAS oncoproteins
#316Method for expanding monocytes
#317SPANX-B polypeptides and their use
#318Targeting deregulated Wnt signaling in cancer using stabilized alpha-helices of BCL-9
#319Chimeric peptides comprising HER-2 B-cell epitopes and Tcell helper epitopes
#320Methods and compositions using listeria for adjuvant treatment of cancer
#321Nucleic acid construct for expression of oxidative stress indicator and use thereof
#322Methods and vectors for cell immortalisation
#323Method for activating helper T cell
#324SiRNA targeting ETS1 and ELK1 and method of using same in the inhibition of CIP2A gene in cancer treatment
#325ErbB interface peptidomimetics and methods of use thereof
#326Modulators of MYC, methods of using the same, and methods of identifying agents that modulate MYC
#327Method for preparing human neoplastically transformed cells
#328Genes from 20q13 amplicon and their uses
#329HER-2 peptides and vaccines
#330Phenotypic reversion of pancreatic carcinoma cells
#331GENE FAMILY (LBFL313) ASSOCIATED WITH PANCREATIC CANCER
#332Translocation and mutant ROS kinase in human non-small cell lung carcinoma
#333TRANSLOCATION AND MUTANT ROS KINASE IN HUMAN NON-SMALL CELL LUNG CARCINOMA
#334Recurrent gene fusions in prostate cancer
#335MYBL2 PEPTIDES AND VACCINES CONTAINING THE SAME
#336INSULIN LIKE PEPTIDES
#337Recurrent gene fusions in prostate cancer
#338Recurrent gene fusions in prostate cancer
#339MOLECULES CAPABLE OF INDUCING CELL DEATH BY TARGETING THE MITOCHONDRIA AND APPLICATIONS THEREOF
#340NOVEL IDENTIFIED ONCOGENE WITH KINASE-DOMAIN (NOK)
#341Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571
#342Process for producing poxviruses and poxvirus compositions
#343Fish cancer model
#344Tumor specific animal proteins
#345JNK3 MODULATORS AND METHODS OF USE
#346MODULATORS OF CELL CYCLE PROGRESSION
#347Methods of treating cancer by administering an Axl ligand-binding portion of an Axl tyrosine kinase receptor extracellular domain
#348Brachyury polypeptides and methods for use
#349Novel Ubiquitin-Isopeptide Probes
#350THERAPEUTIC PEPTIDES, POLYPEPTIDES AND NUCLEIC ACID SEQUENCES
#351HUMAN CANCER-RELATED GENE, ITS ENCODED PRODUCTS AND APPLICATIONS
#352MUTANT RAS POLYPEPTIDE CRYSTAL
#353CRIPTO ANTAGONISM OF ACTIVIN AND TGF-B SIGNALING
#354Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
#355Agents capable of downregulating an MSF-A-dependent HIF-1alpha and use thereof in cancer treatment
#356Method for expanding monocytes
#357Process for producing poxviruses and poxvirus compositions
#358CRIPTO ANTAGONISM OF ACTIVIN AND TGF-B SIGNALING
#359Methods for producing microRNAs
#360Biomarkers, methods and kits for the diagnosis of rheumatoid arthritis
#361Anti-TNF induced apoptosis (ATIA) diagnostic markers and therapies
#362Use of the GTPase Rab27B to diagnose and treat poor prognosis estrogen-receptor-positive breast cancer
#363Anti-5T4 antibodies and uses thereof
#364PEPTIDE INDUCING XAGE-1B-SPECIFIC IMMUNE REACTION AND UTILIZATION OF SAME
#365Albumin fusion proteins
#366Methods of diagnosing and treating prostate cancer characterized by NDRG1-ERG fusion
#367GENES AND POLYPEPTIDES RELATING TO HUMAN PANCREATIC CANCERS
#368Cancer antigen eEF2
#369MUTATIONS IN THE BCR-ABL TYROSINE KINASE ASSOCIATED WITH RESISTANCE TO STI-571
#370MN gene and protein
#371SPANX-B polypeptides and their use
#372Method of detecting tumor-associated DNA in plasma or serum with a premalignant solid tumor
#373ANTIBODIES AND PROCESSES FOR PREPARING THE SAME
#374THERAPEUTIC AGENT FOR MLL LEUKEMIA AND MOZ LEUKEMIA OF WHICH MOLECULAR TARGET IS M-CSF RECEPTOR, AND USE THEREOF
#375Methods and Compositions for Promoting Bone Growth
#376p185-encoding DNA and therapeutical uses thereof
#377MN Gene and Protein
#378Method for treating or preventing bladder cancer using the DEPDC1 polypeptide
#379COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CANCER AND NEURODEGENERATIVE DISEASES RLATED TO BECLIN-1
#380TUMOR ANGIOGENESIS ASSOCIATED GENES AND A METHOD FOR THEIR IDENTIFICATION
#381SIRNA CAPABLE OF INHIBITING THE EXPRESSION OF AN ONCOGENE INVOLVED IN CERVICAL CANCER
#382Gene fusion targeted therapy
#383Method of detecting tumor-associated hypermethylated DNA in plasma or serum
#384DETECTION OF GRANULOSA-CELL TUMORS
#385Antibody-induced apoptosis
#386Senescene Cells and Methods For Its Production
#387Polypeptides that bind to and inhibit secretion from growth hormone secreting cells
#388Immunogenic peptides and methods of use
#389GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF
#390COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#391COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#392Methods for treating muscle diseases and disorders
#393ORGANIC COMPOUNDS
#394RESTORATION OF ESTROGEN RECEPTOR-(ALPHA) ACTIVITY
#395MCT-1, A HUMAN ONCOGENE
#396METHODS OF LONG-TERM CULTURE OF EUKARYOTIC CELLS AND USES THEREOF
#397Promoter and viral vector containing the same
#398Chimeric peptides comprising HER-2 B-cell epitopes and T-helper epitopes
#399p185-encoding DNA and therapeutical uses thereof
#400Mesothelioma Specific Transferred Promoter And Use Thereof
#401Detection of gleevec resistance
#402Animal Model of Synovial Sarcoma
#403Tumour-specific animal proteins
#404Method of detecting tumor-associated DNA in plasma or serum from humans without cancer
#405PARASPORIN-1 RECEPTOR AND USE THEREOF
#406COOPERATING ONCOGENES IN CANCER
#407Recurrent gene fusions in prostate cancer
#408Episomal fusion gene
#409APOPTOTIC PATHWAY TARGETING FOR THE DIAGNOSIS AND TREATMENT OF CANCER
#410Axl fusion proteins as Axl tyrosine kinase inhibitors
#411Q3 SPARC DELETION MUTANT AND USES THEREOF
#412Cripto antagonism of activin and TGF-b signaling
#413Albumin fusion proteins
#414RhoC-based immunotherapy
#415HDM2-inhibitor complexes and uses thereof
#416Translocation and mutant ROS kinase in human non-small cell lung carcinoma
#417Conditionally immortalized long-term stem cells and methods of making and using such cells
#418MN Gene and Protein
#419TUMOR SUPPRESSOR GENE SCREENING USING RNA INTERFERENCE LIBRARIES AND METHOD OF TREATMENT
#420Tumour-Specific Animal Proteins
#421NOVEL SERPENTINE TRANSMEMBRANE ANTIGENS EXPRESSED IN HUMAN CANCERS AND USES THEREOF
#422HDM2 polypeptides
#423CUDR as biomarker for cancer progression and therapeutic response
#424MN/CA IX and cancer prognosis
#425TREATMENT OF INFLAMMATORY DISEASES
#426Method of Cancer Treatment with Antagonists of FAS Inhibitors
#427Transgenic animals comprising gene fusions
#428MUTATIONS IN THE BCR-ABL TYROSINE KINASE ASSOCIATED WITH RESISTANCE TO STI-571
#429ErbB interface peptidomimetics and methods of use thereof
#430SYNTHETIC HLA BINDING PEPTIDE ANALOGUES AND USES THEREOF
#431Translocation and mutant ROS kinase in human non-small cell lung carcinoma
#432Ras mutation and compositions and methods related thereto
#433PROGNOSTIC MARKER FOR BREAST CANCER AND COMPOSITION FOR INDUCING OBESITY COMPRISING HCCR-1
#434Antibodies to human ErbB4
#435MONOCLONAL ANTIBODIES TO ACTIVATED ERBB FAMILY MEMBERS AND METHODS OF USE
#436Eukaryotic layered vector initiation systems
#437MN gene and protein
#438PEPTIDES DERIVED FROM RAS-P21 AND USES THEREFOR
#439TRANSLOCATION AND MUTANT ROS KINASE IN HUMAN NON-SMALL CELL LUNG CARCINOMA
#440COMPOSITIONS FOR REPROGRAMMING A CELL AND USES THEREFOR
#441METHOD FOR DETECTING THE BINDING BETWEEN MDM2 AND THE PROTEASOME
#442TRANSGENIC NON-HUMAN MAMMAL WITH AN ONCOGENIC MUTANT OF THE c-Raf-1 GENE
#443Antibody to a guanine nucleotide exchange factor
#444ErbB interface peptidomimetics and methods of use thereof
#445BCR-ABL variants
#446Multivalent antibody constructs
#447Genes and polypeptides relating to human pancreatic cancers
#448MN Gene and Protein
#449ErbB interface peptidomimetics and methods of use thereof
#450Mutated peptides for generation of CD8 cytotoxic T lymphocytes
#451Mutations in the Bcr-Abl tyrosine kinase associated with resistance to ST1-571
#452Modulators of MYC, methods of using the same, and methods of identifying agents that modulate MYC
#453Brachyury polypeptides and methods for use
#454Compositions employing alternative reading frame polypeptides for the treatment of cancer and infectious disease
#455Peptide having ability to activate cancer-related gene
#456Peptide having ability to activate cancer-related gene
#457Peptide having ability to activate cancer-related gene
#458Process for producing poxviruses and poxvirus compositions
#459Method for expanding monocytes
#460Antibodies to PRO352
#461Methods and compositions for treatment of retinoid-responsive conditions
#462RECONSTITUTED HISTONE METHYLTRANSFERASE COMPLEX AND METHODS OF IDENTIFYI NG MODULATORS THEREOF
#463Evaluation of diseases and conditions associated with translocated genes using plasma or serum DNA
#464Antibodies and processes for preparing the same
#465BARB4 TARGET, ANTIBODY DESIGNATED BARB4, BARB4 RELATED ANTIBODIES, AND METHODS OF MAKING AND USING SAME
#466PHENOTYPIC REVERSION OF PANCREATIC CARCINOMA CELLS
#467ErbB interface peptidomimetics and methods of use thereof
#468Tumor antigen based on products of the tumor suppressor gene WT1
#469Compositions, splice variants and methods relating to ovarian specific genes and proteins
#470CANCER ANTIGEN PEPTIDE FORMULATIONS
#471Target gene mimitin of myc
#472CIRCULAR DNA MOLECULE HAVING A CONDITIONAL ORIGIN OF REPLICATION, PROCESS FOR THEIR PREPARATION AND THEIR USE IN GENE THERAPY
#473Glial mitogenic factors, their preparation and use
#474CUDR AS BIOMARKER FOR CANCER PROGRESSION AND THERAPEUTIC RESPONSE
#475Conditionally-Immortalised Pancreatic Cells
#476Short isoform of annexin A10 at chromosome 4q, termed annexin 10s (ANXA 10s) and methods of use
#477NOVEL IDENTIFIED ONCOGENE WITH KINASE-DOMAIN (NOK)
#478Human Protooncogene and Protein Encoded By Same
#479Cell-based RNA interference and related methods and compositions
#480Inhibitor peptides
#481Target substance capturing molecule
#482CACNA1E in Cancer Diagnosis, Detection and Treatment
#483PRO1120 polypeptides
#484Recurrent gene fusions in prostate cancer
#485ORGANIC COMPOUNDS
#486GENE FAMILY (LBFL313) ASSOCIATED WITH PANCREATIC CANCER
#487Nucleic acid and corresponding protein entitled 213P1F11 useful in treatment and detection of cancer
#488MN/CA IX and cancer prognosis
#489DIRECTED COMPLEMENTATION WITH REMOVABLE GENE OF INTEREST
#490Mammalian cell line expressing inducible c-Src
#491Genes from the 20q13 amplicon and their uses
#492Mutations in the BCR-ABL tyrosine kinase associated with resistance to STI-571
#493Plasmid PXL3179 or NV1FGF
#494Tumor antigen based on products of the tumor suppressor gene WT1
#495SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THE SAME
#496Antibody-induced apoptosis
#497Method of Diagnosing, Monitoring, Staging, Imaging and Treating Prostate Cancer
#498GEF-H1b: biomarkers, complexes, assays and therapeutic uses thereof
#499Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy
#500Human Protooncogene TRG and Protein Encoded Therein
#501MN Gene and Protein
#502Albumin Fusion Proteins
#503Agents capable of downregulating an MSF-A dependent HIF-1α and use thereof in cancer treatment
#504Albumin Fusion Proteins
#505HDM2-INHIBITOR COMPLEXES AND USES THEREOF
#506Methods for producing microRNAs
#507Genes from the 20Q13 amplicon and their uses
#508Episomal fusion gene
#509MATERIALS AND METHODS FOR INHIBITING WIP1
#510ErbB4 antagonists
#511Methods for Detecting Papillomavirus DNA in Blood Plasma and Serum
#512Methods and compositions for regulating T cell subsets by modulating transcription factor activity
#513PRO1190 polypeptides
#514Optical Disc Apparatus
#515Sirna capable of inhibiting the expression of an oncogene involved in cervical cancer
#516Inhibitors of proteins from the Rho-GEF family
#517TUMOR ANGIOGENESIS ASSOCIATED GENES AND A METHOD FOR THEIR IDENTIFICATION
#518Immunogenic peptides and methods of use
#519Orthotopic, controllable, and genetically tractable non-human animal model for cancer
#520Methods for treating muscle diseases and disorders
#521Antagonist of the oncogenic activity of the protein MDM2, and use thereof in the treatment of cancers
#522COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#523COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#524COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#525Detection of gleevec resistance
#526Tumor mouse models using lentiviral vectors
#527Fish cancer model
#528Cancer specific promoters
#529G-PROTEIN COUPLED RECEPTORS HIGH-THROUGHPUT FUNCTIONAL ASSAY
#530SATB1: A DETERMINANT OF MORPHOGENESIS AND TUMOR METASTASIS
#531Gene Encoding a Guanine Nucleotide Exchange Factor and Its Gene Product
#532Methods of screening for supracolonic neoplasms based on stool samples containing a nucleic acid marker indicative of a neoplasm
#533oncogene as a prognostic indicator for lung cancer
#534Expression systems using mammalian beta-actin promoter
#535Animal models of pancreatic adenocarcinoma and uses therefor
#536Glial mitogenic factors, their preparation and use
#537Methods and compositions of IG20 and DENN-SV splice variants
#538Methods for selecting cancer vaccine therapies using extracellular DNA
#539Methods for selecting monoclonal antibody therapies using extracellular DNA
#540COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#541MN Gene and Protein
#542Human Rgr oncogene and truncated transcripts thereof detected in T cell malignancies, antibodies to the encoded polypeptides and methods of use
#543COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#544COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#545COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#546COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#547Animal model for cancer, methods of producing the same and associated methods of use
#548MN Gene and Protein
#549Albumin fusion proteins
#550Human Protooncogene and Protein Encoded Therein
#551Human Protooncogene and Protein Encoded by Same, and Expression Vector Containing Same
#552COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#553COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#554COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#555COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#556MN Gene and Protein
#557Method of Detection of Alterations in MSH5
#558Frizzled proteins and detection and treatment of cancer
#559MN gene and protein
#560NON-MAMMALIAN TRANSGENIC ANIMAL MODEL FOR CELLULAR PROLIFERATIVE DISEASES
#561FRA-1 EXPRESSION IN BRAIN CANCER
#562Q3 SPARC DELETION MUTANT AND USES THEREOF
#563MN Gene and Protein
#564Albumin Fusion Proteins
#565Albumin fusion proteins comprising insulin polypeptides
#566Mutated Src oncogene composition and methods
#567Albumin Fusion Proteins
#568Phenotypic reversion of pancreatic carcinoma cells
#569G-CSF-albumin fusion proteins
#570Gene Overexpressed in Cancer
#571MN Gene and Protein
#572Albumin fusion proteins
#573Method and Nucleic Acids For the Differentiation of Astrocytoma, Oligoastrocytoma and Oligodenroglioma Tumor Cells
#574Composition For Screening Anti-Hypertension Drug Comprising Mammal Tctp Gene or Its Protein Product, and Method For Screening Anti-Hypertension Drug Using Said Composition
#575Hepatocytes
#576Detection of nucleic acid mutation associated with cancer by analysis of saliva
#577Methods of using BCL-2 for the therapeutic treatment and prevention of diseases
#578Cancer suppressing agent
#579Detection of gleevec resistant mutations
#580Materials and methods for inhibiting Wip1
#581Non-Human Animal Models for B-cell Non-Hodgkin's Lymphoma and Uses Thereof
#582TRANSIENTLY IMMORTALIZED CELLS FOR USE IN GENE THERAPY
#583Regulation of oncogenesis by Akt-specific isoforms
#584Detection of extracellular tumor-associated nucleic acid in blood plasma or serum using nucleic acid amplification assay
#585SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THE SAME
#586Gene Encoding a Guanine Nucleotide Exchange Factor Binding to Rhoa
#587CUDR as biomarker for cancer progression and therapeutic response
#588Methods for regulating T cell subsets by modulating transcription factor activity
#589Antibodies against the PRO1754 polypeptides
#590METHOD AND NUCLEIC ACIDS FOR THE ANALYSIS OF ASTROCYTOMAS
#591Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer
#592Strategy for Leukemia Therapy
#593P185 -encoding DNA and therapeutical uses thereof
#594Chimeric cancer models
#595Method of protein extraction from cells
#596Crystal Structure of Erbb2 and Uses Thereof
#597Novel Therapeutic Targets in Cancer
#598Method of detecting the expression of PPN/MG61 and the use of it
#599SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THE SAME
#600PRO1477 polypeptides